John A. Barrett
Plus aucun poste en cours
Historique de carrière de John A. Barrett
Anciens postes connus de John A. Barrett
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ADAMS RESOURCES & ENERGY, INC. | Directeur/Membre du Conseil | - | 10/03/2005 |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2003 | 01/01/2005 |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Corporate Officer/Principal | 01/01/2000 | 01/01/2003 |
| ALAUNOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - | - |
| PHIO PHARMACEUTICALS CORP. | Corporate Officer/Principal | 22/04/2019 | - |
| Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | - | - |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Directeur Technique/Scientifique/R&D | 01/01/1993 | - |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/08/2005 | - |
Formation de John A. Barrett
| St. John's University | Doctorate Degree |
| The State University of New York | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 11 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ADAMS RESOURCES & ENERGY, INC. | Distribution Services |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| PHIO PHARMACEUTICALS CORP. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
| Rorer Pharmaceuticals, Inc. |
- Bourse
- Insiders
- John A. Barrett
- Expérience
